A carregar...
P04.65 Towards new therapies for glioblastoma treatment: role of Dkk-3 and Claudin-5
BACKGROUND: Glioblastomas (GBM) are highly aggressive brain tumors commonly treated with a combination of surgery, radiation therapy, and systemic chemotherapy. However, despite recent improvement in the multimodality approach, patient median survival times range between 3 and 30 months. New data by...
Na minha lista:
| Publicado no: | Neuro Oncol |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6144314/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.299 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|